Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| PARABILIS MEDICINES INC | 0 | 6,412,780 | +6,412,780 | 0 | 175,518 | 15.95% | +175,518 |
| SEAPORT THERAPEUTICS INC | 0 | 6,294,951 | +6,294,951 | 0 | 136,600 | 12.42% | +136,600 |
| BEAM THERAPEUTICS INC(BEAM) | 4,540,132 | 4,540,132 | 0 | 108,191 | 155,772 | 14.16% | +47,581 |
| RAPPORT THERAPEUTICS INC(RAPP) | 3,728,738 | 3,728,738 | 0 | 116,672 | 155,377 | 14.12% | +38,704 |
| ERASCA INC(ERAS) | 7,091,557 | 7,091,557 | 0 | 114,741 | 129,917 | 11.81% | +15,176 |
| VIR BIOTECHNOLOGY INC(VIR) | 12,916,663 | 12,694,163 | -222,500 | 115,733 | 129,354 | 11.76% | +13,620 |
| GENERATE BIOMEDICINES INC(GENB) | 1,944,426 | 1,944,426 | 0 | 24,305 | 32,802 | 2.98% | +8,497 |
| BOUNDLESS BIO INC | 0 | 2,694,095 | +2,694,095 | 0 | 6,735 | 0.61% | +6,735 |
| 10X GENOMICS INC(TXG) | 217,834 | 217,834 | 0 | 4,625 | 8,352 | 0.76% | +3,727 |
| MAZE THERAPEUTICS INC(MAZE) | 4,120,053 | 4,120,053 | 0 | 122,984 | 122,984 | 11.18% | 0 |
| GOSSAMER BIO INC | 8,055,916 | 8,055,916 | 0 | 2,646 | 1,326 | 0.12% | -1,320 |
| Q32 BIO INC | 320,482 | 0 | -320,482 | 2,057 | 0 | — | -2,057 |
| LYELL IMMUNOPHARMA INC | 3,247,162 | 3,247,162 | 0 | 65,138 | 45,525 | 4.14% | -19,613 |